| The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. SFJ Kato M, Paranjape T, Müller RU, Nallur S, Gillespie E, Keane K, Esquela ... Oncogene 28 (25), 2419-24, 2009 | 265 | 2009 |
| Current standards for clinical management of small cell lung cancer AF Farago, FK Keane Translational lung cancer research 7 (1), 69, 2018 | 204 | 2018 |
| Assessing the interactions between radiotherapy and antitumour immunity C Grassberger, SG Ellsworth, MQ Wilks, FK Keane, JS Loeffler Nature reviews Clinical oncology 16 (12), 729-745, 2019 | 202 | 2019 |
| A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis T Paranjape, H Heneghan, R Lindner, FK Keane, A Hoffman, ... The lancet oncology 12 (4), 377-386, 2011 | 167 | 2011 |
| Contemporary radiotherapy: present and future RA Chandra, FK Keane, FEM Voncken, CR Thomas The Lancet 398 (10295), 171-184, 2021 | 157 | 2021 |
| Clinical outcomes in patients with metastatic lung cancer treated with PD-1/PD-L1 inhibitors and thoracic radiotherapy WL Hwang, A Niemierko, KL Hwang, H Hubbeling, E Schapira, JF Gainor, ... JAMA oncology 4 (2), 253-255, 2018 | 96 | 2018 |
| A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer ES Ratner, FK Keane, R Lindner, RA Tassi, T Paranjape, M Glasgow, ... Oncogene 31 (42), 4559-4566, 2012 | 96 | 2012 |
| Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era FK Keane, YH Chen, BA Neville, RB Tishler, JD Schoenfeld, PJ Catalano, ... Cancer 121 (15), 2594-2602, 2015 | 78 | 2015 |
| The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate‐risk disease FK Keane, MH Chen, D Zhang, MJ Loffredo, PW Kantoff, AA Renshaw, ... Cancer 120 (12), 1787-1793, 2014 | 56 | 2014 |
| Intraoperative radiotherapy in the era of intensive neoadjuvant chemotherapy and chemoradiotherapy for pancreatic adenocarcinoma FK Keane, JY Wo, CR Ferrone, JW Clark, LS Blaszkowsky, JN Allen, ... American journal of clinical oncology 41 (6), 607-612, 2018 | 43 | 2018 |
| Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk. WJB Pelletier C, Speed WC, Paranjape T, Keane K, Blitzblau R, Hollestelle A ... Cell Cycle 10 (1), 90-9, 2011 | 41 | 2011 |
| Liver-directed radiotherapy for hepatocellular carcinoma FK Keane, JY Wo, AX Zhu, TS Hong Liver Cancer 5 (3), 198-209, 2016 | 38 | 2016 |
| Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate‐risk disease FK Keane, MH Chen, D Zhang, BJ Moran, MH Braccioforte, AV D'Amico Cancer 121 (16), 2713-2719, 2015 | 33 | 2015 |
| Pre-treatment neutrophil-lymphocyte ratio is associated with overall mortality in localized non-small cell lung cancer treated with stereotactic body radiotherapy N Sebastian, T Wu, J Bazan, E Driscoll, H Willers, N Yegya-Raman, ... Radiotherapy and oncology 134, 151-157, 2019 | 29 | 2019 |
| Intraoperative radiation therapy (IORT) for borderline resectable and locally advanced pancreatic ductal adenocarcinoma (BR/LA PDAC) in the era of modern neoadjuvant treatment … JM Harrison, JY Wo, CR Ferrone, NK Horick, FK Keane, M Qadan, ... Annals of Surgical Oncology 27, 1400-1406, 2020 | 28 | 2020 |
| Targeted resequencing of the microRNAome and 3′ UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer X Chen, T Paranjape, C Stahlhut, T McVeigh, F Keane, S Nallur, N Miller, ... Oncogene 34 (16), 2125-2137, 2015 | 28 | 2015 |
| Differential inflammatory response dynamics in normal lung following stereotactic body radiation therapy with protons versus photons Y Li, M Dykstra, TD Best, J Pursley, N Chopra, FK Keane, MJ Khandekar, ... Radiotherapy and Oncology 136, 169-175, 2019 | 25 | 2019 |
| Role and future directions of external beam radiotherapy for primary liver cancer FK Keane, TS Hong Cancer Control 24 (3), 1073274817729242, 2017 | 21 | 2017 |
| Radiotherapy for biliary tract cancers FK Keane, AX Zhu, TS Hong Seminars in Radiation Oncology 28 (4), 342-350, 2018 | 19 | 2018 |
| Assessment of a Contralateral Esophagus–Sparing Technique in Locally Advanced Lung Cancer Treated With High-Dose Chemoradiation: A Phase 1 Nonrandomized Clinical Trial SC Kamran, BY Yeap, CA Ulysse, C Cronin, CL Bowes, B Durgin, ... JAMA oncology 7 (6), 910-914, 2021 | 18 | 2021 |
